Compare HOWL & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOWL | DOMH |
|---|---|---|
| Founded | 2017 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.7M | 53.1M |
| IPO Year | 2021 | 2010 |
| Metric | HOWL | DOMH |
|---|---|---|
| Price | $0.94 | $0.80 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 405.8K | 218.2K |
| Earning Date | 11-13-2026 | 11-10-2026 |
| Dividend Yield | N/A | ★ 110.91% |
| EPS Growth | 18.40 | ★ 34.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $123,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 578.41 |
| 52 Week Low | $0.27 | $0.63 |
| 52 Week High | $1.20 | $5.10 |
| Indicator | HOWL | DOMH |
|---|---|---|
| Relative Strength Index (RSI) | 41.24 | 29.18 |
| Support Level | $0.88 | N/A |
| Resistance Level | $0.99 | $3.39 |
| Average True Range (ATR) | 0.06 | 0.17 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 0.00 | 19.27 |
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
Dominari Holdings Inc is a holding company that, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading, asset management, and insurance. In addition to capital investment, Dominari provides management support to the executive teams of its subsidiaries, helping them to operate efficiently and reduce costs under a streamlined infrastructure. The Company operates in two reportable business segments: Dominari Financial and Legacy AIkido, with the majority of revenue from Dominari Financial.